Medartis Holding AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDRSF research report →
Price Chart
About the company
Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticated medical devices are engineered to support the surgical repair and stabilization of bone fractures, specifically targeting injuries in both upper and lower limbs, as well as intricate cranio-maxillofacial surgeries.
- CEO
- Matthias Schupp
- IPO
- 2020
- Employees
- 1,337
- HQ
- Basel, BS, CH
Get TickerSpark's AI analysis on MDRSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.43B
- P/E
- 75.33
- Fwd P/E
- 77.71
- PEG
- 0.02
- P/S
- 3.66
- P/B
- 3.99
- EV/EBITDA
- 38.59
- Div Yield
- 0.00%
- Gross Margin
- 77.48%
- Op Margin
- 1.61%
- Net Margin
- 4.86%
- ROE
- 5.35%
- ROIC
- 0.61%
Latest fiscal year · YoY change
- Revenue
- $269.26M+19.8%
- Gross Profit
- $204.33M+14.4%
- Op Income
- $1.93M
- Net Income
- $8.35M+136.6%
- EPS
- $0.67+157.7%
- OCF Growth
- +8.6%
- FCF Growth
- -55.5%
- 52W High
- $115.00
- 52W Low
- $66.68
- 50D MA
- $115.00
- 200D MA
- $109.08
- Beta
- 1.17
- RSI (14)
- 100
- Avg Volume
- 171
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the MDRSF Q2 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 32.6%
- Shares Outstanding
- 12.45M
- Float Shares
- 4.06M
Our MDRSF coverage
Recent articles, reports, and earnings notes.
No research on MDRSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MDRSF report →Medartis Holding AG (MDRSF) Q2 2026 Press Conference Call Transcript
seekingalpha.com · Aug 18
Medartis Holding AG (MDRSF) Discusses Strategy Roadmap and Innovation in Upper Extremities and Hand Products Transcript
seekingalpha.com · Jun 4
Medartis Holding AG (OTCMKTS:MDRSF) Short Interest Down 12.8% in February
defenseworld.net · Mar 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.